IV Drips Sold as ‘Detoxification’ Actually Contained Toxins; Over 30 Poisoned Across Four States

Over 30 people across four states have been poisoned by IV drips at wellness clinics, according to the Centers for Disease Control and Prevention and the Food and Drug Administration. The patients received injections containing glutathione, a natural antioxidant sold without evidence for things like detoxification, immune support and skin brightening.

Glutathione has been studied as a possible treatment for various ailments, but there is little to no evidence-backed use for the tripeptide. There are no FDA-approved glutathione products in the United States.

What Went Wrong

The problem was not the ingredient itself. It was how it was prepared. Compounding pharmacies making IV drips used glutathione powders graded for dietary supplements taken orally. That grading is critically different from purified products graded for sterile injectable drugs.

The FDA announced late last month that it had learned at least two compounding pharmacies were doing this, and that people were getting sick. At the time, the agency had received reports of at least 30 sickened people.

The Companies Involved

The IV glutathione products involved appeared to be made from glutathione provided by Medisca Inc., headquartered in Plattsburgh, New York. “The glutathione was labeled as dietary supplement grade, which is not an appropriate ingredient to make injectable drugs,” the FDA said.

Medisca told the FDA that it had informed its pharmacy customers not to use the product for injectable drugs.

“The glutathione was labeled as dietary supplement grade, which is not an appropriate ingredient to make injectable drugs.”

The Order of Events

1. Wellness clinics began offering IV glutathione as a supplement.
2. Compounding pharmacies supplied glutathione powder graded for oral use.
3. Patients received IV drips containing the improperly graded ingredient.
4. Over 30 people across four states were poisoned.
5. The FDA announced it had learned of the practice and the illnesses.
6. Medisca told the FDA it had warned its pharmacy customers about the issue.

What the Public Should Know

The CDC and FDA have linked the illnesses to IV drips containing glutathione, which is most often used in pill form, taken by mouth. Wellness clinics offering IV drips of vitamins and other supplements have also been offering glutathione.

The exact number of people affected is not stated beyond the FDA’s initial report of at least 30. The illnesses occurred across four states.

The case raises questions about regulation in the wellness industry. Glutathione is a natural substance with some scientific interest, but it has no approved medical use. Selling it as an IV injection carries risks the FDA says were ignored.

The FDA’s announcement was a warning. The CDC’s involvement suggests a public health investigation is underway. The fact that Medisca acknowledged the issue and told its customers to stop is a sign the company recognized the mistake.

This is not a minor oversight. The FDA’s warning and the CDC’s involvement show the government is paying attention.

The FDA’s warning is a call to action. Wellness clinics should verify the ingredients in their IV drips. Patients should ask questions before agreeing to an injection. Regulators should enforce standards consistently across all medical practices.

The story is still developing. More details may emerge as the CDC and FDA continue their investigation. For now, the lesson is simple: IV drips should be treated with care.

Source material: “IV drips used for "detoxification" actually filled with toxins; dozens poisoned,” Ars Technica.

FDA warning · glutathione · IV drip · poisoning · wellness clinic